SEC Form 4 · accession 0001209191-17-005769
CHIMERIX INC · CMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
M Michelle Berrey
Officer — President and CEO · Director
Period of report
Jan 24, 2017
Accepted (ET)
Jan 26, 2017 · 5:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001117480
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 24, 2017 | A | 74,000 | $0.00 | A | 362,161 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $5.14 | Jan 24, 2017 | A | 148,000 | A | — | Jan 23, 2027 | Common Stock | 148,000 | 148,000 | D |
Explanation of responses
- F1The shares being reported are being issued pursuant to restricted stock unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs shall vest on January 24, 2018, 25% of the RSUs shall vest on January 24, 2019, 25% of the RSUs shall vest on January 24, 2020 and the remaining 25% of the RSUs shall vest on January 24, 2021.
- F21/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.